These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33886692)

  • 1. Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis.
    Assal M; Lambert J; Chow-Chine L; Bisbal M; Servan L; Gonzalez F; de Guibert JM; Faucher M; Vey N; Sannini A; Mokart D
    PLoS One; 2021; 16(4):e0250611. PubMed ID: 33886692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study.
    Kamel T; Janssen-Langenstein R; Quelven Q; Chelly J; Valette X; Le MP; Bourenne J; Garot D; Fillatre P; Labruyere M; Heming N; Lambiotte F; Lascarrou JB; Lesieur O; Bachoumas K; Ferre A; Maury E; Chalumeau-Lemoine L; Bougon D; Roux D; Guisset O; Coudroy R; Boulain T;
    Intensive Care Med; 2024 Aug; 50(8):1228-1239. PubMed ID: 38829531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study.
    Kumagai S; Arita M; Koyama T; Kumazawa T; Inoue D; Nakagawa A; Kaji Y; Furuta K; Fukui M; Tomii K; Taguchi Y; Tomioka H; Ishida T
    BMC Pulm Med; 2019 Feb; 19(1):47. PubMed ID: 30791907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients.
    Moon SM; Kim T; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4613-8. PubMed ID: 21788460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study.
    Gaborit BJ; Tessoulin B; Lavergne RA; Morio F; Sagan C; Canet E; Lecomte R; Leturnier P; Deschanvres C; Khatchatourian L; Asseray N; Garret C; Vourch M; Marest D; Raffi F; Boutoille D; Reignier J
    Ann Intensive Care; 2019 Nov; 9(1):131. PubMed ID: 31776705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome.
    Wieruszewski PM; Barreto JN; Frazee E; Daniels CE; Tosh PK; Dierkhising RA; Mara KC; Limper AH
    Chest; 2018 Sep; 154(3):636-644. PubMed ID: 29705221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
    Lécuyer R; Issa N; Tessoulin B; Lavergne RA; Morio F; Gabriel F; Canet E; Bressollette-Bodin C; Guillouzouic A; Boutoille D; Raffi F; Lecomte R; Le Turnier P; Deschanvres C; Camou F; Gaborit BJ;
    J Infect Dis; 2022 Mar; 225(5):868-880. PubMed ID: 34604908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia.
    Inoue N; Fushimi K
    Int J Infect Dis; 2019 Feb; 79():109-115. PubMed ID: 30529109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.
    Azoulay E; Roux A; Vincent F; Kouatchet A; Argaud L; Rabbat A; Mayaux J; Perez P; Pène F; Nyunga M; Bruneel F; Klouche K; Mokart D; Darmon M; Chevret S; Lemiale V
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1519-1526. PubMed ID: 29995433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
    Giacobbe DR; Dettori S; Di Pilato V; Asperges E; Ball L; Berti E; Blennow O; Bruzzone B; Calvet L; Capra Marzani F; Casabella A; Choudaly S; Dartevel A; De Pascale G; Di Meco G; Fallon M; Galerneau LM; Gallego M; Giacomini M; González Sáez A; Hänsel L; Icardi G; Koehler P; Lagrou K; Lahmer T; Lewis White P; Magnasco L; Marchese A; Marelli C; Marín-Arriaza M; Martin-Loeches I; Mekontso-Dessap A; Mikulska M; Mularoni A; Nordlander A; Poissy J; Russelli G; Signori A; Tascini C; Vaconsin LM; Vargas J; Vena A; Wauters J; Pelosi P; Timsit JF; Bassetti M; ;
    Crit Care; 2023 Aug; 27(1):323. PubMed ID: 37620828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020.
    Hosseini-Moghaddam SM; Kothari S; Humar A; Albasata H; Yetmar ZA; Razonable RR; Neofytos D; D'Asaro M; Boggian K; Hirzel C; Khanna N; Manuel O; Mueller NJ; Imlay H; Kabbani D; Tyagi V; Smibert OC; Nasra M; Fontana L; Obeid KM; Apostolopoulou A; Zhang SX; Permpalung N; Alhatimi H; Silverman MS; Guo H; Rogers BA; MacKenzie E; Pisano J; Gioia F; Rapi L; Prasad GVR; Banegas M; Alonso CD; Doss K; Rakita RM; Fishman JA
    Am J Transplant; 2024 Apr; 24(4):653-668. PubMed ID: 37977229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia.
    Huang YM; Lu CH; Cheng CF; Shen CY; Hsieh SC; Li KJ; Chien JY; Hsueh PR;
    Int J Infect Dis; 2022 Sep; 122():1018-1025. PubMed ID: 35918031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous corticosteroid exposure associates with an increased
    Vargas Barahona L; Molina KC; Pedraza-Arévalo LC; Sillau S; Tagawa A; Scherger S; Chastain DB; Shapiro L; Tuells J; Franco-Paredes C; Hawkins KL; Maloney JP; Thompson GR; Henao-Martínez AF
    Ther Adv Infect Dis; 2023; 10():20499361231159481. PubMed ID: 36938147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.
    Fillatre P; Chevrier S; Revest M; Gacouin A; Jouneau S; Leroy H; Robert-Gangneux F; Minjolle S; Le Tulzo Y; Tattevin P
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):189-94. PubMed ID: 22930407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
    Cordonnier C; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Alanio A; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Maertens J;
    J Antimicrob Chemother; 2016 Sep; 71(9):2379-85. PubMed ID: 27550990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Host factors and characteristics of hospitalized patients with pneumocystis jirovecii pneumonia].
    Chen RX; Sun YX; Liu XN; Shao C; Huang H; Hu K; Xu J; Li J; Yi X; Zhang ZJ; Xu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Sep; 45(9):881-887. PubMed ID: 36097925
    [No Abstract]   [Full Text] [Related]  

  • 19. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
    Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
    Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined immune and inflammatory indicator predict the prognosis of severe Pneumocystis jirovecii pneumonia patients: a 12-year, retrospective, observational cohort.
    Wang D; Guan L; Li X; Tong Z
    BMC Pulm Med; 2024 Jun; 24(1):285. PubMed ID: 38890590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.